http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-4021568-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_66a3c73049079eaff72daf3308fcf42b
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-1038
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B18-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-10
filingDate 2020-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3a67e75186687f91e9c51e57580b1ff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a522bbdc6c753c0a2b353104020cd63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea35c45b1ca3447913643a7c53138bd1
publicationDate 2022-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-4021568-A1
titleOfInvention Post-ablative modulation of radiation therapy
abstract Methods and systems are provided for treating a cancer in a subject, the method comprising providing an ablative dose of radiation therapy to a first region comprising the cancer followed by a sub-ablative dose to a second region, wherein the sub-ablative dose is administered within 1 hour to 4 days after the ablative dose.
priorityDate 2019-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399674
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400188
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136068
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399673
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408624
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53716604
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73949399
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226438275
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6010
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9211
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402323
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441145
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226403924
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID247704
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5816
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54677971
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20055487
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395919
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400189
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413442

Total number of triples: 34.